Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have uncovered an ...

So, study lead author Dr. Francisco Romo-Nava designed a noninvasive spinal cord stimulation method that he has patented.

A $2.5 million federal grant will fund a four-year study led by Kessler Foundation scientist Karen J. Nolan, PhD, to explore ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

New research shows that stimulation of the lumbosacral vertebrae region significantly elevated low blood pressure, unlike cervical or upper thoracic stimulation.